Pharmafile Logo
Pharmafocus logo
Advanced Search

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

November 19, 2024
Chiesi, Corporate, best workplace

Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best …

News
Press release

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

November 18, 2024
barinthius Bio

Eight participants achieved HBsAg loss at any time. Two participants met criteria for functional cure. Two participants who discontinued NUC …

News
Press release

Antibacterial peptides instrumental in efficiency against resistant bacteria

November 18, 2024
Research and Development AMR, Chalmers Institute of Technology, Infections and infestations, MRSA, antibacterial peptides

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, …

News

Spinal cord stimulator with AI technology receives CE Mark certification

November 13, 2024
Research and Development AI, EU, Nevro, Pain, spinal cord stimulation

The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …

News

J&J seek approval for first drug to treat high-risk smoldering myeloma

November 13, 2024
Research and Development FDA, J&J, Rare Diseases, bone marrow

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the …

News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024
Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …

News

CMS commences formal review for Topical Oxygen Therapy coverage

November 11, 2024
Wound Healing, topical oxygen therapy, wound care

11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …

News
Press release

Johnson & Johnson receive MHRA approval for BALVERSA

November 8, 2024
Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer

BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …

News

SolasCure partners with US Army for better wound care technology

November 6, 2024
Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …

News

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

November 5, 2024
Research and Development NorthWest Ehealth, clinical trials

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …

News
Press release

FlyPharma Vienna 2024: An Event to Remember!

November 4, 2024
Corporate, FlyPharma 2024, Samedan, event

Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …

News
Press release

Valneva Scotland supports local cancer charity Team Jak Foundation 

October 31, 2024
Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines

Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …

News
Press release

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma

October 30, 2024
Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors

Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …

News

Darrin Schellin appointed new CEO at Pharma Tech Industries

October 30, 2024
CEO, Pharma Tech Industries, manufacturing and packaging, pharmaceutical

Pharma Tech Industries, a pharmaceutical manufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment …

Appointment

HIV vaccine candidate successfully optimised for industrial production

October 30, 2024
Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …

News
cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024
Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …

News

From molecule to market and beyond: Uniphar announces extended global commercialization platform

October 25, 2024
CRO, UniPhar, cell and gene

22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …

News
Press release

Shawn Cross appointed as chief financial officer for Pacira Biosciences

October 25, 2024
Research and Development Pacira Biosciences

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …

Appointment

VALIANT phase 3 trial results highlight potential treatment for rare kidney diseases

October 25, 2024
Nephrology, Rare Diseases, rare kidney disease, trial

SOBI and Apellis Pharmaceuticals have announced the results from the VALIANT trial, which highlight that systemic pegcetacoplan treatment could benefit …

News

Stelis, Strides and Steriscience merge to form new CDMO

October 22, 2024
Research and Development CMDO, CPhI, Corporate, bangalore, merger

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025